Literature DB >> 23205669

MicroRNAs and lymphomagenesis: a functional review.

Charles H Lawrie1.   

Abstract

The relatively recent discovery of microRNAs (miRNAs) has exposed an extra layer of gene expression regulation that affects many physiological and pathological processes of biology. Dysregulation of miRNAs is a ubiquitous feature of cancer in general, including lymphomas. The identity of these aberrantly-expressed miRNAs has been thoroughly investigated in all but a few types of lymphomas, however their functional role in lymphomagenesis much less so. This review focuses on those miRNAs that have an experimentally confirmed functional role in the pathogenesis of the most frequent forms of lymphoma. In particular, the MIR15A/16-1 cluster, MIR21, MIR155, MIR17HG (MIR17-92 cluster), MIR34A and MIR125B, which have in vivo animal model evidence for their involvement in lymphomagenesis, are highlighted.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23205669     DOI： 10.1111/bjh.12157

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  40 in total

Review 1.  Role of miR-155 in the regulation of lymphocyte immune function and disease.

Authors:  Nabila Seddiki; Vedran Brezar; Nicolas Ruffin; Yves Lévy; Sanjay Swaminathan
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

2.  Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.

Authors:  Javeed Iqbal; Yulei Shen; Xin Huang; Yanyan Liu; Laura Wake; Cuiling Liu; Karen Deffenbacher; Cynthia M Lachel; Chao Wang; Joseph Rohr; Shuangping Guo; Lynette M Smith; George Wright; Sharathkumar Bhagavathi; Karen Dybkaer; Kai Fu; Timothy C Greiner; Julie M Vose; Elaine Jaffe; Lisa Rimsza; Andreas Rosenwald; German Ott; Jan Delabie; Elias Campo; Rita M Braziel; James R Cook; Raymond R Tubbs; James O Armitage; Dennis D Weisenburger; Louis M Staudt; Randy D Gascoyne; Timothy W McKeithan; Wing C Chan
Journal:  Blood       Date:  2014-12-10       Impact factor: 22.113

3.  miRNA-target gene regulatory networks: A Bayesian integrative approach to biomarker selection with application to kidney cancer.

Authors:  Thierry Chekouo; Francesco C Stingo; James D Doecke; Kim-Anh Do
Journal:  Biometrics       Date:  2015-01-30       Impact factor: 2.571

4.  Downregulated expression of Dicer1 predicts inferior survival in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab.

Authors:  Haifeng Zhao; Le Zhang; Shanqi Guo; Tian Yuan; Bing Xia; FuLian Qu; Lianyu Zhang; Yizhuo Zhang
Journal:  Med Oncol       Date:  2014-09-07       Impact factor: 3.064

5.  Bim regulation miRrors microRNA 17∼92 cluster expression in endothelial cells in vivo.

Authors:  X W Meng; S H Kaufmann
Journal:  Cell Death Differ       Date:  2014-11       Impact factor: 15.828

6.  MicroRNAs in diffuse large B-cell lymphoma.

Authors:  Huiyun Ni; Rong Tong; Linqing Zou; Guoqi Song; William C Cho
Journal:  Oncol Lett       Date:  2015-12-28       Impact factor: 2.967

7.  MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma.

Authors:  Juan Sandoval; Angel Díaz-Lagares; Rocío Salgado; Octavio Servitje; Fina Climent; Pablo L Ortiz-Romero; Amparo Pérez-Ferriols; Maria P Garcia-Muret; Teresa Estrach; Mar Garcia; Lara Nonell; Manel Esteller; Ramon M Pujol; Blanca Espinet; Fernando Gallardo
Journal:  J Invest Dermatol       Date:  2014-11-18       Impact factor: 8.551

8.  MicroRNA-related polymorphisms and non-Hodgkin lymphoma susceptibility in the Multicenter AIDS Cohort Study.

Authors:  Erin C Peckham-Gregory; Dharma R Thapa; Jeremy Martinson; Priya Duggal; Sudhir Penugonda; Jay H Bream; Po-Yin Chang; Sugandha Dandekar; Shen-Chih Chang; Roger Detels; Otoniel Martínez-Maza; Zuo-Feng Zhang; Shehnaz K Hussain
Journal:  Cancer Epidemiol       Date:  2016-10-01       Impact factor: 2.984

9.  miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1.

Authors:  Marek Mraz; Liguang Chen; Laura Z Rassenti; Emanuela M Ghia; Hongying Li; Kristen Jepsen; Erin N Smith; Karen Messer; Kelly A Frazer; Thomas J Kipps
Journal:  Blood       Date:  2014-05-01       Impact factor: 22.113

10.  Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables.

Authors:  Semra Paydas; Arbil Acikalin; Melek Ergin; Hikmet Celik; Basak Yavuz; Kahraman Tanriverdi
Journal:  Med Oncol       Date:  2016-03-07       Impact factor: 3.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.